Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2025-12-17 @ 12:03 AM
Study NCT ID:
NCT04787510
Status:
None
Last Update Posted:
2021-09-28 00:00:00
First Post:
2021-03-04 00:00:00
Brief Title:
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Sponsor:
University Hospital Ioannina
Organization:
University Hospital, Ioannina
Study Overview
Official Title:
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Status:
None
Status Verified Date:
2021-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.
Association between clotting factors levels and disease severity,morbidity and mortality in these patients.
Effect of anticoagulant therapy in the clotting factors' levels in these patients
Association between clotting factors levels and disease severity,morbidity and mortality in these patients.
Effect of anticoagulant therapy in the clotting factors' levels in these patients
Detailed Description:
Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection
Association between clotting factors levels and disease severitymorbidity and mortality in these patients
Effect of anticoagulant therapy in the clotting factors levels in these patients
Association between clotting factors levels and disease severitymorbidity and mortality in these patients
Effect of anticoagulant therapy in the clotting factors levels in these patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None